Suzanne V Arnold1, Philip G Jones2, Larry A Allen2, David J Cohen2, Timothy J Fendler2, Jonathan E Holtz2, Sanjeev Aggarwal2, John A Spertus2. 1. From the Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A., P.G.J., D.J.C., T.J.F., S.A., J.A.S.); University of Missouri-Kansas City (S.V.A., D.J.C., T.J.F., J.A.S.); University of Colorado, Denver (L.A.A.); and University of Pittsburgh, PA (J.E.H.). suz.v.arnold@gmail.com. 2. From the Saint Luke's Mid America Heart Institute, Kansas City, MO (S.V.A., P.G.J., D.J.C., T.J.F., S.A., J.A.S.); University of Missouri-Kansas City (S.V.A., D.J.C., T.J.F., J.A.S.); University of Colorado, Denver (L.A.A.); and University of Pittsburgh, PA (J.E.H.).
Abstract
BACKGROUND: A left ventricular assist device (LVAD) improves survival and quality of life for many, but not all, patients with end-stage heart failure who are ineligible for transplantation. We sought to evaluate the frequency of poor outcomes using a novel composite measure that integrates quality of life with mortality. METHODS AND RESULTS: Within the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) national registry, poor outcome was defined as death or an average Kansas City Cardiomyopathy Questionnaire <45 during the year after LVAD (persistently limiting heart failure symptoms and poor quality of life). Among 1638 patients with LVAD, 29.7% had a poor outcome, with death in 22.4% and persistently poor quality of life in 7.3%. Patients who had a poor outcome were more likely to have higher body mass indices (29.3 versus 28.2 kg/m(2); P=0.007), lower hemoglobin levels (11.1 versus 11.4 g/dL; P=0.005), previous cardiac surgery (47.8% versus 39.8%; P=0.004), history of cancer (13.8% versus 9.7%; P=0.025), severe diabetes mellitus (15.6% versus 11.5%; P=0.038), and poorer quality of life preimplant (Kansas City Cardiomyopathy Questionnaire scores: 29.8 versus 35.3; P<0.001). CONCLUSIONS: Nearly one third of patients die or have a persistently poor quality of life during the year after LVAD. We identified several factors associated with a poor outcome, which may inform discussions before LVAD implantation to enable more realistic expectations of recovery.
BACKGROUND: A left ventricular assist device (LVAD) improves survival and quality of life for many, but not all, patients with end-stage heart failure who are ineligible for transplantation. We sought to evaluate the frequency of poor outcomes using a novel composite measure that integrates quality of life with mortality. METHODS AND RESULTS: Within the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) national registry, poor outcome was defined as death or an average Kansas City Cardiomyopathy Questionnaire <45 during the year after LVAD (persistently limiting heart failure symptoms and poor quality of life). Among 1638 patients with LVAD, 29.7% had a poor outcome, with death in 22.4% and persistently poor quality of life in 7.3%. Patients who had a poor outcome were more likely to have higher body mass indices (29.3 versus 28.2 kg/m(2); P=0.007), lower hemoglobin levels (11.1 versus 11.4 g/dL; P=0.005), previous cardiac surgery (47.8% versus 39.8%; P=0.004), history of cancer (13.8% versus 9.7%; P=0.025), severe diabetes mellitus (15.6% versus 11.5%; P=0.038), and poorer quality of life preimplant (Kansas City Cardiomyopathy Questionnaire scores: 29.8 versus 35.3; P<0.001). CONCLUSIONS: Nearly one third of patients die or have a persistently poor quality of life during the year after LVAD. We identified several factors associated with a poor outcome, which may inform discussions before LVAD implantation to enable more realistic expectations of recovery.
Authors: Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock Journal: N Engl J Med Date: 2010-09-22 Impact factor: 91.245
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: Kelsey M Flint; Daniel D Matlock; Kartik S Sundareswaran; Joann Lindenfeld; John A Spertus; David J Farrar; Larry A Allen Journal: J Heart Lung Transplant Date: 2013-10-08 Impact factor: 10.247
Authors: Matthew C Iacovetto; Daniel D Matlock; Colleen K McIlvennan; Jocelyn S Thompson; William Bradley; Shane J LaRue; Larry A Allen Journal: Circ Cardiovasc Qual Outcomes Date: 2014-10-14
Authors: Joseph G Rogers; Keith D Aaronson; Andrew J Boyle; Stuart D Russell; Carmelo A Milano; Francis D Pagani; Brooks S Edwards; Soon Park; Ranjit John; John V Conte; David J Farrar; Mark S Slaughter Journal: J Am Coll Cardiol Date: 2010-04-27 Impact factor: 24.094
Authors: Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier Journal: N Engl J Med Date: 2007-08-30 Impact factor: 91.245
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2013-02 Impact factor: 10.247
Authors: Windy W Alonso; Kenneth M Faulkner; Bunny J Pozehl; Judith E Hupcey; Lisa A Kitko; Christopher S Lee Journal: Res Nurs Health Date: 2020-07-06 Impact factor: 2.228
Authors: David M Harmon; Kristen M Tecson; Aayla K Jamil; Joost Felius; Gonzalo V Gonzalez-Stawinski; Susan M Joseph; Shelley A Hall Journal: Proc (Bayl Univ Med Cent) Date: 2019-03-28
Authors: Quin E Denfeld; Christopher S Lee; William R Woodward; Shirin O Hiatt; James O Mudd; Beth A Habecker Journal: J Cardiovasc Nurs Date: 2019 Jul/Aug Impact factor: 2.083
Authors: Suzanne V Arnold; David J Cohen; David Dai; Philip G Jones; Fan Li; Laine Thomas; Suzanne J Baron; Naftali Z Frankel; Susan Strong; Roland A Matsouaka; Fred H Edwards; J Matthew Brennan Journal: Circ Cardiovasc Qual Outcomes Date: 2018-10
Authors: Boyla O Mainsah; Priyesh A Patel; Xinlin J Chen; Cameron Olsen; Leslie M Collins; Ravi Karra Journal: J Am Heart Assoc Date: 2021-03-04 Impact factor: 5.501
Authors: Murat Sezgin; Murat Bülent Rabuş; Emre Selçuk; Özge Altaş; Sabit Sarıkaya; Mehmet Balkanay; Mehmet Kaan Kırali Journal: Turk Gogus Kalp Damar Cerrahisi Derg Date: 2020-01-23 Impact factor: 0.332
Authors: Kelsey M Flint; John A Spertus; Fengming Tang; Philip Jones; Timothy J Fendler; Larry A Allen Journal: BMC Cardiovasc Disord Date: 2017-03-14 Impact factor: 2.298